Systematic Review: The Impact of COVID-19 Vaccination on Myocarditis Risk and Recovery
Vaccine-associated myocarditis is rare, typically mild, and self-limited, with excellent short-term recovery; vaccinated individuals also exhibit lower odds of in-hospital death and intubation. In contrast, infection-associated myocarditis is more frequent and severe. Overall, the benefit-risk profile of mRNA vaccination remains strongly favorable.
Authors
- Vishwanath Venketaraman (ORCID: https://orcid.org/0000-0002-2586-1160)
- Christopher Khatchadourian
- Luke Sanders
- Jackson Lewis
- Quincy Eweroke
- Joaquin Santos
- Cyvannah Warner-McCutcheon
- Yibo Liu (ORCID: https://orcid.org/0009-0002-7533-9570)
Institutions
- Philadelphia College of Osteopathic Medicine (US)
- University of Southern California (US)
- Los Angeles Medical Center (US)
- Western University of Health Sciences (US)
Publication Details
- Journal
- Clinics and Practice
- Published
- 2026-04-17
- DOI
- https://doi.org/10.3390/clinpract16040077
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute